Condition: Epithelial Ovarian Cancer · Ovarian Neoplasms · Advanced Ovarian Cancer · Sponsor: Azienda USL Reggio Emilia - IRCCS
This is a multicenter, observational, retrospective and prospective study conducted within the REMO (Reggio Emilia - Modena) network in the Emilia-Romagna region (Italy), promoted by AUSL-IRCCS of Reggio Emilia. The study aims to evaluate the impact of surgical centralization and treatment strategies adopted during the COVID-19 pandemic on oncologic outcomes in patients diagnosed with the epithelial ovarian cancer (EOC) from 2018 to 2023. The retrospective component includes patients treated between 2018 and 2023, while the prospective component consists of clinical follow-up of those patients over the next five years.
This description comes directly from the study's public registry record.
Vincenzo Dario Mandato, MD - Principal Investigator · +39 0522 295467 · vincenzodario.mandato@ausl.re.it
Jasmine Lonetti · +39 0522 295467 · jasmine.lonetti@ausl.re.it
Always discuss trial participation with your own doctor first.
| Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi | Carpi, Modena, Italy | Recruiting |
| Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola | Mirandola, Modena, Italy | Recruiting |
| Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano | Pavullo nel Frignano, Modena, Italy | Not Yet Recruiting |
| Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo | Sassuolo, Modena, Italy | Recruiting |
| Azienda Unità - Sanitaria locale di Modena - Ospedale di Vignola | Vignola, Modena, Italy | Not Yet Recruiting |
| Azienda USL IRCCS di Reggio Emilia | Reggio Emilia, RE, Italy | Recruiting |
| Azienda Ospedaliero - Universitario di Modena | Modena, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07075939